Want to join the conversation?
$GILD said it appointed Kevin Young CBE as COO and Martin Silverstein as EVP, Strategy. Both Young and Silverstein will report to John Milligan, President and CEO. The company also said Paul Carter, EVP, Commercial Operations, has decided to depart $GILD and pursue other opportunities.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?